Publications

Detailed Information

Volumetric differences in the pituitary between drug-naive and medicated male patients with obsessive-compulsive disorder

DC Field Value Language
dc.contributor.authorJung, Myung Hun-
dc.contributor.authorHuh, Min Jung-
dc.contributor.authorKang, Do-Hyung-
dc.contributor.authorChoi, Jung-Seok-
dc.contributor.authorJang, Joon Hwan-
dc.contributor.authorHan, Ji Yeon-
dc.contributor.authorKwon, Jun Soo-
dc.contributor.authorChoi, Chi-Hoon-
dc.contributor.authorPark, Ji-Young-
dc.contributor.authorJung, Wi Hoon-
dc.date.accessioned2012-07-05T02:36:34Z-
dc.date.available2012-07-05T02:36:34Z-
dc.date.issued2009-06-15-
dc.identifier.citationPROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY; Vol.33(4); 605-609ko_KR
dc.identifier.issn0278-5846-
dc.identifier.urihttps://hdl.handle.net/10371/78570-
dc.description.abstractObjective: Obsessive-compulsive symptoms are induced or aggravated by stress, and the pituitary is a key component of the hypothalamic-pituitary-adrenal axis. We examined pituitary volume in drug-naive and medicated male patients with obsessive-compulsive disorder (OCD). Methods: Volumetric magnetic resonance imaging studies were conducted on 62 male control subjects, medicated male patients (N = 50) and drug-naive male patients (N = 12) with OCD. Results: Pituitary volume was significantly smaller in drug-naive patients with OCD (464.97 +/- 55.82 mm(3)) compared to medicated patients (577.84 +/- 129.11 mm(3), P=0.004) and control subjects (543.04 +/- 113.70 mm(3), P=0.027), and no difference between control subjects and medicated patients (P=0.174). Conclusion: The results indicate that drug-naive male patients with OCD exhibit decreased pituitary volume. This finding suggests that dysregulation of the HPA axis in OCD may influence pituitary volume. In addition, the increased pituitary volume in medicated patients may reflect the effect of drugs on the pituitary.ko_KR
dc.language.isoenko_KR
dc.publisherPERGAMON-ELSEVIER SCIENCE LTDko_KR
dc.subjectMagnetic resonance imagingko_KR
dc.subjectPituitary glandko_KR
dc.subjectObsessive-compulsive disorderko_KR
dc.titleVolumetric differences in the pituitary between drug-naive and medicated male patients with obsessive-compulsive disorderko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor정명훈-
dc.contributor.AlternativeAuthor허민정-
dc.contributor.AlternativeAuthor강도형-
dc.contributor.AlternativeAuthor최정석-
dc.contributor.AlternativeAuthor정이훈-
dc.contributor.AlternativeAuthor장준환-
dc.contributor.AlternativeAuthor박지영-
dc.contributor.AlternativeAuthor한지연-
dc.contributor.AlternativeAuthor최치훈-
dc.contributor.AlternativeAuthor권준수-
dc.identifier.doi10.1016/j.pnpbp.2009.02.017-
dc.citation.journaltitlePROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY-
dc.description.citedreferenceEker C, 2008, PROG NEURO-PSYCHOPH, V32, P1628, DOI 10.1016/j.pnpbp.2008.05.023-
dc.description.citedreferenceOberlander TF, 2008, EARLY HUM DEV, V84, P689, DOI 10.1016/j.earlhumdev.2008.06.008-
dc.description.citedreferencePARIANTE CM, 2008, J PSYCHOPHARMACOL, V22, P76-
dc.description.citedreferenceKluge M, 2007, J PSYCHIATR RES, V41, P928, DOI 10.1016/j.jpsychires.2006.08.005-
dc.description.citedreferenceCromer KR, 2007, BEHAV RES THER, V45, P1683, DOI 10.1016/j.brat.2006.08.018-
dc.description.citedreferenceHeisler LK, 2007, J NEUROSCI, V27, P6956, DOI 10.1523/JNEUROSCI.2584-06.2007-
dc.description.citedreferenceMacMaster FP, 2007, SCHIZOPHR RES, V92, P207, DOI 10.1016/j.schres.2007.01.022-
dc.description.citedreferenceMacMaster FP, 2007, LIFE SCI, V80, P940, DOI 10.1016/j.lfs.2006.11.040-
dc.description.citedreferenceMondelli V, 2006, PSYCHONEUROENDOCRINO, V31, P1139, DOI 10.1016/j.psyneuen.2006.08.006-
dc.description.citedreferenceMacMaster FP, 2006, BIOL PSYCHIAT, V60, P862, DOI 10.1016/j.biopsych.2006.04.013-
dc.description.citedreferenceKluge M, 2006, PSYCHONEUROENDOCRINO, V31, P1098, DOI 10.1016/j.psyneuen.2006.07.002-
dc.description.citedreferenceMacMaster FP, 2006, BIOL PSYCHIAT, V59, P252, DOI 10.1016/j.biopsych.2005.06.028-
dc.description.citedreferencePariante CM, 2005, NEUROPSYCHOPHARMACOL, V30, P1923, DOI 10.1038/sj.npp.1300766-
dc.description.citedreferenceMcCracken JT, 2005, J CHILD ADOL PSYCHOP, V15, P581-
dc.description.citedreferenceChoi JS, 2004, J PSYCHIAT RES, V38, P193, DOI 10.1016/j.jpsychires.2003.08.001-
dc.description.citedreferenceMikkelsen JD, 2004, ANN NY ACAD SCI, V1018, P65, DOI 10.1196/annals.1296.007-
dc.description.citedreferenceFindley DB, 2003, J AM ACAD CHILD PSY, V42, P450, DOI 10.1097/01.CHI.0000046816.95464.EF-
dc.description.citedreferenceNickel T, 2003, J CLIN PSYCHOPHARM, V23, P155-
dc.description.citedreferenceTandon R, 2003, PSYCHONEUROENDOCRINO, V28, P1, DOI 10.1016/S0306-4530(02)00109-9-
dc.description.citedreferenceSassi RB, 2001, BIOL PSYCHIAT, V50, P271-
dc.description.citedreferenceContesse V, 2000, CAN J PHYSIOL PHARM, V78, P967-
dc.description.citedreferenceSapolsky RM, 2000, ENDOCR REV, V21, P55-
dc.description.citedreferenceKunwar S, 1999, J CLIN ENDOCR METAB, V84, P4385-
dc.description.citedreferenceLjubic-Thibal V, 1999, SYNAPSE, V32, P177-
dc.description.citedreferenceDinc H, 1998, ACTA RADIOL, V39, P64-
dc.description.citedreferenceWILSON JD, 1998, WILLIAMS TXB ENDOCRI-
dc.description.citedreferenceSchwartz PJ, 1997, PSYCHIAT RES-NEUROIM, V74, P151-
dc.description.citedreferenceMichelson D, 1996, NEUROPSYCHOPHARMACOL, V15, P207-
dc.description.citedreferenceChappell P, 1996, BIOL PSYCHIAT, V39, P776-
dc.description.citedreferenceFIRST MB, 1996, STRUCTURED CLIN INTE-
dc.description.citedreferenceGOUDREAU JL, 1995, NEUROENDOCRINOLOGY, V62, P147-
dc.description.citedreferenceBARDEN N, 1995, TRENDS NEUROSCI, V18, P6-
dc.description.citedreferenceMONTELEONE P, 1994, ACTA PSYCHIAT SCAND, V89, P411-
dc.description.citedreferenceBAILLY D, 1994, BIOL PSYCHIAT, V35, P143-
dc.description.citedreference*AM PSYCH ASS, 1994, DIAGN STAT MAN MENT-
dc.description.citedreferenceLUCEY JV, 1993, ACTA PSYCHIAT SCAND, V87, P384-
dc.description.citedreferenceCATAPANO F, 1992, PSYCHIAT RES, V44, P217-
dc.description.citedreferenceAXELSON DA, 1992, PSYCHIAT RES, V44, P63-
dc.description.citedreferenceDORAISWAMY PM, 1992, AM J NEURORADIOL, V13, P1295-
dc.description.citedreferenceGOUDREAU JL, 1992, NEUROENDOCRINOLOGY, V56, P100-
dc.description.citedreferenceALTEMUS M, 1992, ARCH GEN PSYCHIAT, V49, P9-
dc.description.citedreferenceTANDON R, 1991, BIOL PSYCHIAT, V29, P953-
dc.description.citedreferenceKRISHNAN KRR, 1991, J CLIN ENDOCR METAB, V72, P256-
dc.description.citedreferenceDORAISWAMY PM, 1991, PROG NEURO-PSYCHOPH, V15, P351-
dc.description.citedreferenceZOHAR J, 1991, PSYCHOBIOLOGY OBSESS-
dc.description.citedreferenceWEIZMAN R, 1990, CLIN NEUROPHARMACOL, V13, P297-
dc.description.citedreferenceLURIE SN, 1990, J CLIN ENDOCR METAB, V71, P505-
dc.description.citedreferenceGEHRIS TL, 1990, PSYCHIAT RES, V32, P151-
dc.description.citedreferenceELSTER AD, 1990, RADIOLOGY, V174, P681-
dc.description.citedreferenceCATAPANO F, 1990, NEUROPSYCHOBIOLOGY, V23, P53-
dc.description.citedreferenceSUZUKI M, 1990, J COMPUT ASSIST TOMO, V14, P36-
dc.description.citedreferenceGOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006-
dc.description.citedreferenceCOTTRAUX JA, 1984, PSYCHIAT RES, V13, P157-
dc.description.citedreferenceFRIEDMAN E, 1983, ENDOCRINOLOGY, V112, P1943-
dc.description.tc4-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share